drugset / Trial / NCT01571817

Pancreatic Islet Transplantation Into the Gastric Submucosa

NCT01571817 ↗

Phase 1 Completed 1 enrolled Andrew Posselt
NaSingle-groupOpen-labelTreatment

Summary

The overall objective of this pilot project is to evaluate the safety and efficacy of the gastric submucosal space as a novel site for clinical islet transplantation. The site has several physiologic attributes that may improve the outcomes of islet transplantation compared with the conventional intraportal transplant site.

Timeline

Start
2012-04
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Isolated Human Pancreatic Islets Cell therapy — Other